相关实验视频

Updated: Jul 13, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

莱特-7i在瘤进展中的双重机制

Jiapei Zhou¹, Hongjie Xiang², Zhiqun Cao¹

¹First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.

Frontiers in oncology

|October 13, 2023

概括

Let-7i微RNA在癌症中起着双重作用,通过表观遗传和后转录来调节基因表达. 它显示出作为癌症生物标志物和治疗点的潜力,影响瘤进展和耐药性.

科学领域:

分子生物学分子生物学
遗传学是一个遗传学.
在瘤学瘤学.

背景情况:

微RNAs (miRNAs) 是基因表达的关键调节者.
Let-7i是一种特定的miRNA,已涉及到各种生物过程.
了解Let-7i在癌症中的作用对于开发新的诊断和治疗方法至关重要.

研究的目的:

阐明Let-7i在瘤发生中的多方面的调节机制.
探索Let-7i作为癌症诊断和预后生物标志物的潜力.
研究Let-7i在癌症治疗中的治疗影响.

主要方法:

分析Let-7i与mRNA3'未翻译区域 (3' UTRs) 的结合,用于转录后调节.
通过DNA甲基化调制来研究Let-7i的表观遗传功能.
评估Let-7i对关键癌症特征的影响,包括扩散,迁移,入侵,亡,EMT,EV传播,血管生成,自和耐药性.

主要成果:

Let-7i在癌症中表现出双重作用,根据其特定的点促进或抑制恶性瘤.
莱特-7i影响关键的癌细胞行为,影响增殖,迁移,入侵,亡,EMT,EV传播,血管生成,自和耐药性.
Let-7i被认为是癌症诊断和预后的潜在生物标志物.

结论:

Let-7i是癌症的重要调节剂,通过后转录和表观遗传机制起作用.
Let-7i的复杂作用凸显了其作为一个多功能生物标志物和治疗点的潜力.
调节Let-7i,可能通过外体修饰,可以促进抗癌免疫反应,并产生瘤抑制作用.

关键词:

让-7i成为i.癌症癌症癌症癌症癌症双重机制是双重的机制.抑制剂抑制剂的作用活动主办人活动主办人

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

The Soft Agar Colony Formation Assay

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mechanisms of Retrovirus-induced Cancers

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...